Support for LAist comes from
We Explain L.A.
Stay Connected

Share This


Pharmaceutical Sued, California Wins

LAist relies on your reader support.
Your tax-deductible gift today powers our reporters and keeps us independent. We rely on you, our reader, not paywalls to stay funded because we believe important news and information should be freely accessible to all.

In the largest ever multi-state consumer protection-based pharmaceutical settlement, California will receive $5.6 million--the largest share of the $62 Million, 32 state settlement--from medicine maker Eli Lilly and Company, the makers of antipsychotic drug Zyprexa. “Eli Lilly put profits ahead of patients when it marketed Zyprexa for a use that had not been properly tested or approved, in many cases, putting young women at risk for weight gain, hypoglycemia and even diabetes,” Attorney General Brown said a statement released today. Eli Lilly was accused of engaging "in unfair and deceptive practices when it marketed Zyprexa for off-label uses and [failing] to adequately disclose the drug’s potential side effects to healthcare providers."